Patent · US Active

Methods of administering interferon gamma to absorb fluid from the subretinal space

US9486502B2 · kind B2 · utility

0Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2014
Grant dateNov 8, 2016
Priority date
Expiry dateApr 14, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Particular aspects of the invention provide methods for decreasing the amount of fluid present in the subretinal space of the eye by administering interferon gamma to the basolateral side of the retinal pigment epithelium. Adverse ocular conditions associated with the accumulation of fluid in the subretinal space can be treated by administering an amount of interferon gamma to the basolateral side of the retinal pigment epithelium effective to remove excess fluid from the subretinal space.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.